Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is not for human consumption, therapeutic use, or self-experimentation
The goal is to pause the specific activity causing pain while maintaining low-impact movement like walking, swimming, or cycling
Research-grade specs Components: GHK-Cu + BPC-157 + TB-500 Total strength: 70 mg per vial Format: Lyophilized powder, single-vial blend CAS Number: N/A (blend) Pathways studied: Matrix remodelling (GHK-Cu), cell migration and signalling (BPC-157, TB-500) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Copper-peptide and tripeptide comparative research Cytoskeletal and matrix pathway interaction research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
"Below standalone injury range" means the blend delivers less of that compound than a standalone injury protocol would
Mechanism of Action How It Works in the Body 1
To view a copy of this licence, visit About this article Cite this article Ryan, D.H., Lingvay, I., Deanfield, J
